Thanks for all your contributions to this message board!
Just a thought to add to the discussion and maybe it's been brought up before. Also keep in mind I am by no means knowledgeable in this field so might be talking out my a$$!
What if there have been preliminary discussions with Big Pharma for a buyout. Koos knows the approximate worth of what RGBP is sitting on and so do the potential suitors and maybe they are in the same ballpark. However, Big Pharma needs 3rd party validation of the value of RGBP for the sake of justifying the cost to their shareholders to purchase a company at a considerable premium to RGBP's current market cap? Hence the introduction of Biotech Research Group to the puzzle?
Just food for thought in my late night, early morning ramblings :)
Thanks for all those who offer positive contributions on here. It was this board that got me interested and initially investing in RGBP.
Good luck all,
tcubed